Pharmaceuticals

Global Quinolones Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Quinolones Industry In 2025?

The quinolones market has demonstrated consistent growth in its size over recent years. Its value is projected to increase from $50.05 billion in 2024 to $51.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.7%. This historic expansion can be attributed to elements such as the demand for and usage of antibiotics, various regulatory approvals, ongoing research and development efforts, the prevailing competitive landscape, and patent expirations.

The quinolones market is projected for significant expansion over the coming years, with its size expected to reach $63.17 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period is attributable to several factors, including the emergence of new diseases, shifts in regulatory frameworks, evolving global health policies, an increase in antibiotic resistance, and strategic market expansion initiatives. Key trends expected during this period involve the development of novel products and alterations in the regulatory environment.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

Which Industry Drivers Are Expected To Accelerate The Quinolones Market From 2025 To 2029?

An increase in infectious disease cases substantially propels the expansion of the quinolones market. These diseases are health conditions triggered by microorganisms like bacteria, viruses, fungi, and parasites. Quinolones find extensive application in managing various bacterial infectious diseases, including tuberculosis and urinary tract infections. For instance, the Global Tuberculosis Report, published by the Switzerland-based World Health Organization in November 2023, indicated that newly diagnosed global TB cases reached 7.5 million in 2022, an increase from 6.4 million in 2021. Consequently, the growing frequency of infectious diseases is set to propel the quinolones market forward.

What Are The Different Segment Classifications Within The Quinolones Market?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Norfloxacin: Indications, Dosage Forms

2) By Ofloxacin: Indications, Dosage Forms

3) By Ciprofloxacin: Indications, Dosage Forms

4) By Gemifloxacin: Indications, Dosage Forms

5) By Other Types: Various Formulations, Indications

How Are Emerging Market Trends Shaping The Quinolones Industry Landscape?

Product innovation stands out as a key trend increasing in popularity within the quinolones market. Major companies operating in this sector are focusing on developing innovative products to maintain their market position. For instance, in January 2023, the South Korean branch of Viatris, a pharmaceutical company based in the US, launched Dovprela, a new treatment for drug-resistant tuberculosis. Dovprela is a three-drug regimen composed of bedaquiline, pretomanid, and linezolid (BPaL), designed for treating adult patients with extensively drug-resistant TB and multidrug-resistant TB that is treatment-resistant or non-responsive. This medication reduces the treatment period from 18-20 months to 5-6 months, attributed to its rapid anti-tuberculosis effect.

Which Major Firms Are Strengthening Their Position In The Quinolones Industry?

Major companies operating in the quinolones market include Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, Novus, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Regional Markets Are Contributing Most To The Quinolones Industry Expansion?

North America was the largest region in the quinolones market in 2024. The regions covered in the quinolones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Quinolones Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9429&type=smp

Browse Through More Reports Similar to the Global Quinolones Market 2025, By The Business Research Company

Grain Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-products-global-market-report

Grain Farming Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-farming-global-market-report

Grain Alcohol Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/grain-alcohol-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795